These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


801 related items for PubMed ID: 18685378

  • 1. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
    Argilés JM, López-Soriano FJ, Busquets S.
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
    [Abstract] [Full Text] [Related]

  • 2. Cancer cachexia.
    Tisdale MJ.
    Curr Opin Gastroenterol; 2010 Mar; 26(2):146-51. PubMed ID: 19918173
    [Abstract] [Full Text] [Related]

  • 3. Regulation of adipose tissue metabolism in cancer cachexia.
    Bing C, Trayhurn P.
    Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):201-7. PubMed ID: 18403913
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of skeletal muscle atrophy.
    Ventadour S, Attaix D.
    Curr Opin Rheumatol; 2006 Nov; 18(6):631-5. PubMed ID: 17053511
    [Abstract] [Full Text] [Related]

  • 5. The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders.
    Koopman R, Ryall JG, Church JE, Lynch GS.
    Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):601-6. PubMed ID: 19741516
    [Abstract] [Full Text] [Related]

  • 6. Fat loss in cachexia--is there a role for adipocyte lipolysis?
    Rydén M, Arner P.
    Clin Nutr; 2007 Feb; 26(1):1-6. PubMed ID: 17095126
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of cancer cachexia.
    Tisdale MJ.
    Physiol Rev; 2009 Apr; 89(2):381-410. PubMed ID: 19342610
    [Abstract] [Full Text] [Related]

  • 8. On our way to targeted therapy for cachexia in cancer?
    Boddaert MS, Gerritsen WR, Pinedo HM.
    Curr Opin Oncol; 2006 Jul; 18(4):335-40. PubMed ID: 16721127
    [Abstract] [Full Text] [Related]

  • 9. The AP-1/CJUN signaling cascade is involved in muscle differentiation: implications in muscle wasting during cancer cachexia.
    Moore-Carrasco R, García-Martínez C, Busquets S, Ametller E, Barreiro E, López-Soriano FJ, Argilés JM.
    FEBS Lett; 2006 Jan 23; 580(2):691-6. PubMed ID: 16412434
    [Abstract] [Full Text] [Related]

  • 10. Tumor-host interactions.
    Tisdale MJ.
    J Cell Biochem; 2004 Nov 15; 93(5):871-7. PubMed ID: 15449322
    [Abstract] [Full Text] [Related]

  • 11. The pivotal role of cytokines in muscle wasting during cancer.
    Argilés JM, Busquets S, López-Soriano FJ.
    Int J Biochem Cell Biol; 2005 Oct 15; 37(10):2036-46. PubMed ID: 16105746
    [Abstract] [Full Text] [Related]

  • 12. Pathogenesis of cancer cachexia.
    Tisdale MJ.
    J Support Oncol; 2003 Oct 15; 1(3):159-68. PubMed ID: 15334872
    [Abstract] [Full Text] [Related]

  • 13. Muscle wasting in cancer: the role of mitochondria.
    Argilés JM, López-Soriano FJ, Busquets S.
    Curr Opin Clin Nutr Metab Care; 2015 May 15; 18(3):221-5. PubMed ID: 25769061
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of skeletal muscle depletion in wasting syndromes: role of ATP-ubiquitin-dependent proteolysis.
    Costelli P, Baccino FM.
    Curr Opin Clin Nutr Metab Care; 2003 Jul 15; 6(4):407-12. PubMed ID: 12806214
    [Abstract] [Full Text] [Related]

  • 15. Induction of cachexia in mice by systemically administered myostatin.
    Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, Lee SJ.
    Science; 2002 May 24; 296(5572):1486-8. PubMed ID: 12029139
    [Abstract] [Full Text] [Related]

  • 16. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
    Argilés JM, Busquets S, Felipe A, López-Soriano FJ.
    Int J Biochem Cell Biol; 2005 May 24; 37(5):1084-104. PubMed ID: 15743680
    [Abstract] [Full Text] [Related]

  • 17. Muscle wasting in cancer.
    Johns N, Stephens NA, Fearon KC.
    Int J Biochem Cell Biol; 2013 Oct 24; 45(10):2215-29. PubMed ID: 23770121
    [Abstract] [Full Text] [Related]

  • 18. Is there a common mechanism linking muscle wasting in various disease types?
    Tisdale MJ.
    Curr Opin Support Palliat Care; 2007 Dec 24; 1(4):287-92. PubMed ID: 18685377
    [Abstract] [Full Text] [Related]

  • 19. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
    Siddiqui JA, Pothuraju R, Jain M, Batra SK, Nasser MW.
    Biochim Biophys Acta Rev Cancer; 2020 Apr 24; 1873(2):188359. PubMed ID: 32222610
    [Abstract] [Full Text] [Related]

  • 20. Cachexia, survival and the acute phase response.
    Stephens NA, Skipworth RJ, Fearon KC.
    Curr Opin Support Palliat Care; 2008 Dec 24; 2(4):267-74. PubMed ID: 19060563
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.